{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T02:38:04Z","timestamp":1794278284564,"version":"4.9.0"},"reference-count":43,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2000,8,1]],"date-time":"2000-08-01T00:00:00Z","timestamp":965088000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2000,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The mechanisms leading to increased bone loss and skeletal fragility in women with postmenopausal osteoporosis are still poorly understood. Increased bone resorption, low serum estradiol and high serum sex-hormone-binding globulin (SHBG) recently have been reported as predictors of vertebral and hip fractures in elderly women. In a cohort of healthy untreated younger postmenopausal women aged 50\u201389 years (mean, 64 years), we compared baseline levels of bone markers and endogenous hormones in 55 women who subsequently had a fracture (20 vertebral and 35 peripheral fractures) with levels in the 380 women who did not fracture during a mean 5 years of follow-up. Women with levels in the highest quartile of four bone resorption markers including urinary-free deoxypyridinoline (D-Pyr), urinary type I collagen N-telopeptides (NTX), and urinary and serum type I collagen C-telopeptides (CTX) had about a 2-fold increased risk of fractures compared with women with levels in the three lowest quartiles with relative risk (RR) and 95% CI of 1.8 (1.0-3.4) for free D-Pyr, 1.7 (0.9-3.2) for urinary NTX, 2.3 (1.3-4.1) for urinary CTX, and 2.1 (1.2-3.8) for serum CTX. Serum levels of bone alkaline phosphatase (BAP) in the highest quartile were associated with an RR of fracture of 2.4 (1.3-4.2). Women with serum levels of estradiol and dehydroepiandrosterone (DHEA) sulfate in the lowest quartile had an RR of fracture of 2.2 (1.2-4.0) and 2.1 (1.2-3.8), respectively. Increased levels of SHBG and intact parathyroid hormone (PTH) were moderately associated with an increased risk of fracture. Similar results were obtained when the analysis was restricted to symptomatic vertebral and nonvertebral fractures. Adjustment of biochemical markers by hormone levels did not significantly alter the results. Women with both high bone resorption markers and low estradiol (or low DHEA sulfate) had a higher risk of fracture with RRs of 3.0-3.3 (p &amp;lt; 0.001). After adjustment for bone mineral density (BMD) of the hip, spine, radius, or total body, bone markers and hormones were still predictive of fracture risk with similar RRs. We conclude that high levels of some biochemical markers of bone turnover, low serum estradiol, low DHEA sulfate, high SHBG, and high PTH are associated with increased risk of osteoporotic fracture in postmenopausal women, independently of each other and of BMD. The mechanism by which some postmenopausal women have an increased rate of bone turnover leading to an increased risk of fracture remains to be elucidated.<\/jats:p>","DOI":"10.1359\/jbmr.2000.15.8.1526","type":"journal-article","created":{"date-parts":[[2006,4,27]],"date-time":"2006-04-27T03:20:21Z","timestamp":1146108021000},"page":"1526-1536","source":"Crossref","is-referenced-by-count":581,"title":["Biochemical Markers of Bone Turnover, Endogenous Hormones and the Risk of Fractures in Postmenopausal Women: The OFELY Study"],"prefix":"10.1093","volume":"15","author":[{"given":"Patrick","family":"Garnero","sequence":"first","affiliation":[{"name":"INSERM Research Unit 403, H\u00f4pital E Herriot, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Sornay-Rendu","sequence":"additional","affiliation":[{"name":"INSERM Research Unit 403, H\u00f4pital E Herriot, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Claustrat","sequence":"additional","affiliation":[{"name":"Centre de M\u00e9decine nucl\u00e9aire, H\u00f4pital Neuro-cardiologique, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre D.","family":"Delmas","sequence":"additional","affiliation":[{"name":"INSERM Research Unit 403, H\u00f4pital E Herriot, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2009,12,2]]},"reference":[{"key":"2024020714093565200_bib1","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1001\/jama.1941.02820220007002","article-title":"Postmenopausal osteoporosis\u2014its clinical features","volume":"116","author":"Albright","year":"1941","journal-title":"JAMA"},{"key":"2024020714093565200_bib2","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/S0140-6736(80)92592-1","article-title":"Prevention of spinal osteoporosis in oophorectomized women","volume":"2","author":"Lindsay","year":"1980","journal-title":"Lancet"},{"key":"2024020714093565200_bib3","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1172\/JCI118382","article-title":"Sex steroids, bone mass, and bone loss. A prospective study of pre, peri- and postmenopausal women","volume":"97","author":"Slemenda","year":"1996","journal-title":"J Clin Invest"},{"key":"2024020714093565200_bib4","first-page":"2239","article-title":"Associations between low levels of serum estradiol, bone density, and fractures among elderly women: The study of osteoporotic fractures","volume":"83","author":"Ettinger","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2024020714093565200_bib5","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1359\/jbmr.1998.13.7.1167","article-title":"Hormonal predictors of bone loss in elderly women: A prospective study","volume":"13","author":"Stone","year":"1998","journal-title":"J Bone Miner Res"},{"key":"2024020714093565200_bib6","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1056\/NEJM199809103391104","article-title":"Endogeneous hormones and the risk of hip and vertebral fractures among older women","volume":"339","author":"Cummings","year":"1998","journal-title":"N Engl J Med"},{"key":"2024020714093565200_bib7","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/8756-3282(87)90002-0","article-title":"Bone loss and biochemical indices of bone remodeling in surgically induced postmenopausal women","volume":"8","author":"Stepan","year":"1987","journal-title":"Bone"},{"key":"2024020714093565200_bib8","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1002\/jbmr.5650080714","article-title":"Urinary hydroxypyridinium crosslinks of collagen and markers of bone resorption and estrogen efficacy in postmenopausal women","volume":"8","author":"Seibel","year":"1993","journal-title":"J Bone Miner Res"},{"key":"2024020714093565200_bib9","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1210\/jcem-72-2-367","article-title":"Effect of menopause and hormone replacement therapy on the urinary excretion of pyridinium crosslinks","volume":"72","author":"Uebelhart","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"2024020714093565200_bib10","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/jbmr.5650110307","article-title":"Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis","volume":"11","author":"Garnero","year":"1996","journal-title":"J Bone Miner Res"},{"key":"2024020714093565200_bib11","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S0002-9378(12)90897-2","article-title":"Preventive effects of trandermal 17 beta estradiol on osteoporotic changes after surgical menopause: A two-year placebo-controlled trial","volume":"168","author":"Field","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"2024020714093565200_bib12","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S8756-3282(99)00076-9","article-title":"A dose-ranging trial of a matrix transdermal 17 beta estradiol for the prevention of bone loss in early postmenopausal women","volume":"24","author":"Delmas","year":"1999","journal-title":"Bone"},{"key":"2024020714093565200_bib13","first-page":"366","article-title":"The short-term effects of conjugated estrogen on bone turnover in older women","volume":"79","author":"Prestwood","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"2024020714093565200_bib14","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1002\/jbmr.5650111021","article-title":"Markers of bone resorption predict hip fracture risk in elderly women: The EPIDOS Prospective Study","volume":"11","author":"Garnero","year":"1996","journal-title":"J Bone Miner Res"},{"key":"2024020714093565200_bib15","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1136\/bmj.312.7029.482","article-title":"Case-control analysis of bone-resorption markers, disability, and hip fracture: The Rotterdam study","volume":"312","author":"van Daele","year":"1996","journal-title":"BMJ"},{"key":"2024020714093565200_bib16","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1172\/JCI111096","article-title":"Relationship between surface, volume and thickness of iliac trabecular bone in aging and in osteoporosis","volume":"72","author":"Parfitt","year":"1983","journal-title":"J Clin Invest"},{"key":"2024020714093565200_bib17","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1359\/jbmr.1997.12.4.683","article-title":"Apparent pre and postmenopausal bone loss evaluated by DXA at different skeletal sites in women: The Ofely cohort","volume":"12","author":"Arlot","year":"1997","journal-title":"J Bone Miner Res"},{"key":"2024020714093565200_bib18","first-page":"518","article-title":"Assessing vertebral fractures: A report by the National Osteoporosis Working Group on vertebral Fractures","volume":"10","author":"National Osteoporosis Foundation Working Group on Vertebral Fractures","year":"1995","journal-title":"J Bone Miner Res"},{"key":"2024020714093565200_bib19","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1359\/jbmr.1999.14.1.90","article-title":"Defining incident vertebral deformity: A prospective comparison of several approaches","volume":"14","author":"Black","year":"1999","journal-title":"J Bone Miner Res"},{"key":"2024020714093565200_bib20","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1002\/jbmr.5650071206","article-title":"Measurement of serum osteocalcin with a human-specific two-site radioimmunoassay","volume":"7","author":"Garnero","year":"1992","journal-title":"J Bone Miner Res"},{"key":"2024020714093565200_bib21","first-page":"1046","article-title":"Assessment of the serum levels of bone akaline phosphatase with a new immunoradiometric assay in patients with metabolic bone disease","volume":"77","author":"Garnero","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"2024020714093565200_bib22","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1093\/clinchem\/42.6.947","article-title":"Immunoassay for intact amino-terminal propeptide of human type I procollagen","volume":"46","author":"Melkko","year":"1996","journal-title":"Clin Chem"},{"key":"2024020714093565200_bib23","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1002\/jbmr.5650091019","article-title":"Direct, enzyme-linked immunoassay for urinary deoxypyridinoline as a specific marker for measuring bone resorption","volume":"9","author":"Robins","year":"1994","journal-title":"J Bone Miner Res"},{"key":"2024020714093565200_bib24","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1002\/jbmr.5650071119","article-title":"A specific immunoassay for monitoring human bone resorption: Quantitation of type I collagen cross-linked N-telopeptides in urine","volume":"7","author":"Hanson","year":"1992","journal-title":"J Bone Miner Res"},{"key":"2024020714093565200_bib25","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1093\/clinchem\/40.11.2022","article-title":"Immunoassay for quantifying type I collagen degradation products in urine evaluated","volume":"40","author":"Bonde","year":"1994","journal-title":"Clin Chem"},{"key":"2024020714093565200_bib26","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1093\/clinchem\/44.11.2281","article-title":"Serum Crosslaps one step Elisa. First application of monoclonal antibodies for measurement in serum of bone-related degradation products from C-terminal telopeptides of type I collagen","volume":"44","author":"Rosenquist","year":"1998","journal-title":"Clin Chem"},{"key":"2024020714093565200_bib27","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0090-8258(82)90058-0","article-title":"Estradiol, androstenedione, and dehydroepiandrosterone sulfate in the ovarian and peripheral blood of postmenopausal patients with and without endometrial cancer","volume":"14","author":"Bremond","year":"1982","journal-title":"Gynecol Oncol"},{"key":"2024020714093565200_bib28","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1210\/jcem-66-5-951","article-title":"Concurrent assays of circulating bone-gla-protein and bone alkaline phosphatase: Effects of sex, age, and metabolic bone disease","volume":"66","author":"Duda","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"key":"2024020714093565200_bib29","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/BF02556596","article-title":"Serum bone-GLA-protein is not a sensitive marker of bone turnover in Paget's disease of bone","volume":"38","author":"Delmas","year":"1986","journal-title":"Calcif Tissue Int"},{"key":"2024020714093565200_bib30","first-page":"955","article-title":"Markers of bone turnover in hyperthyroidism: Effects of treatment","volume":"78","author":"Garnero","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"2024020714093565200_bib31","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1359\/jbmr.1999.14.9.1614","article-title":"Markers of bone turnover predict forearm bone loss: A 4-yr follow-up study","volume":"14","author":"Garnero","year":"1999","journal-title":"J Bone Miner Res"},{"key":"2024020714093565200_bib32","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/8756-3282(96)00102-0","article-title":"Low bone mass and fast rate of bone loss at menopause: Equal risk factors for future fracture: A 15 year follow-up study","volume":"19","author":"Riis","year":"1996","journal-title":"Bone"},{"key":"2024020714093565200_bib33","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/jbmr.5650100418","article-title":"Different effects of bisphosphonate and estrogen therapy on free and peptide-bound bone crosslinks excretion","volume":"10","author":"Garnero","year":"1995","journal-title":"J Bone Miner Res"},{"key":"2024020714093565200_bib34","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1002\/jbmr.5650110817","article-title":"Comparison of biochemical markers of bone turnover in Paget disease treated with pamidronate and a proposed model for the relationships between measurements of the different forms of pyridinoline crosslinks","volume":"11","author":"Randall","year":"1996","journal-title":"J Bone Miner Res"},{"key":"2024020714093565200_bib35","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S8756-3282(97)00105-1","article-title":"Osteoclasts generate crosslinked collagen N-telopeptides (NTx) but not free pyridinolines when cultured on human bone","volume":"21","author":"Apone","year":"1997","journal-title":"Bone"},{"key":"2024020714093565200_bib36","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1002\/jbmr.5650111220","article-title":"The renal clearance of free and conjugated pyridinium cross-links of collagen","volume":"11","author":"Colwell","year":"1996","journal-title":"J Bone Miner Res"},{"key":"2024020714093565200_bib37","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/1529-0131(199802)41:2<354::AID-ART20>3.0.CO;2-5","article-title":"Measurement of urinary excretion of nonisomerized and \u03b2-isomerized forms of type I collagen breakdown products to monitor the effects of the bisphosphonate zoledronate in Paget's disease","volume":"41","author":"Garnero","year":"1998","journal-title":"Arthritis Rheum"},{"key":"2024020714093565200_bib38","doi-asserted-by":"crossref","first-page":"9755","DOI":"10.1074\/jbc.272.15.9755","article-title":"Characterization of urinary degradation products derived from type I collagen. Identification of a beta-isomerized Asp-Gly sequence within the C-terminal telopeptide (alpha 1) region","volume":"272","author":"Fledelius","year":"1997","journal-title":"J Biol Chem"},{"key":"2024020714093565200_bib39","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1042\/bj3450481","article-title":"Racemization and isomerization of type I collagen C-telopeptides in human bone and soft tissues: assessment of tissue turnover","volume":"345","author":"Gineyts","year":"2000","journal-title":"Biochem J"},{"key":"2024020714093565200_bib40","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1210\/jcem-60-4-651","article-title":"The relation between calcium absorption, serum dehydroepiandrosterone, and vertebral mineral density in postmenopausal women","volume":"60","author":"Nordin","year":"1985","journal-title":"J Clin Endocrinol Metab"},{"key":"2024020714093565200_bib41","first-page":"275","article-title":"Endogeneous cortisol and sex steroids in patients with osteoporotic spinal fractures","volume":"61","author":"Davidson","year":"1983","journal-title":"Obstet Gynecol"},{"key":"2024020714093565200_bib42","first-page":"128","article-title":"The death of osteocytes via apoptosis accompanies estrogen withdrawal in human bone","volume":"82","author":"Tomkinson","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2024020714093565200_bib43","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/BF02555908","article-title":"Bone death in hip fracture in the elderly","volume":"47","author":"Dunstan","year":"1990","journal-title":"Calcif Tissue Int"}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1359%2Fjbmr.2000.15.8.1526","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/15\/8\/1526\/56603820\/5650150812.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/15\/8\/1526\/56603820\/5650150812.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T15:01:04Z","timestamp":1710342064000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/15\/8\/1526-1536\/7515375"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,8,1]]},"references-count":43,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2009,12,2]]},"published-print":{"date-parts":[[2000,8,1]]}},"URL":"https:\/\/doi.org\/10.1359\/jbmr.2000.15.8.1526","relation":{},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2000,8,1]]},"published":{"date-parts":[[2000,8,1]]}}}